A PROSPECTIVE RANDOMIZED TRIAL OF AUTOLOGOUS PLATELET-DERIVED WOUND-HEALING FACTORS FOR TREATMENT OF CHRONIC NONHEALING WOUNDS - A PRELIMINARY-REPORT

被引:111
作者
KRUPSKI, WC [1 ]
REILLY, LM [1 ]
PEREZ, S [1 ]
MOSS, KM [1 ]
CROMBLEHOLME, PA [1 ]
RAPP, JH [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT SURG,SAN FRANCISCO,CA 94143
关键词
D O I
10.1016/0741-5214(91)90247-R
中图分类号
R61 [外科手术学];
学科分类号
摘要
Previous studies have suggested that topically applied platelet-derived wound healing factors (PDWHF) accelerate wound healing by stimulating angiogenesis, fibroblast proliferation, and collagen synthesis. To assess the ability of platelet factors to facilitate healing of chronic cutaneous ulcers we performed a randomized, prospective, double-blind, placebo-controlled study of topical PDWHF in 18 patients with 26 lower extremity wounds refractory to conventional therapy. Wounds were present for at least 8 weeks (mean, 5.5 +/- 4.3 months). They were extensively debrided initially and were measured and photographed at weekly intervals for 12 weeks. Eight patients with nine wounds were treated with placebo solution (controls), and 10 patients with 17 wounds were treated with PDWHF (treatment group). Seventy-eight percent of patients had diabetes mellitus, 72% had occlusive peripheral vascular disease, and 28% had venous disease; distribution of these disorders was equivalent in both groups. Ankle-brachial indexes, which were often spuriously elevated, averaged 0.93 +/- 0.54 in controls and 1.04 +/- 0.56 in patients treated with PDWHF (p > 0.5). Mean transcutaneous oxygen tension was 37.8 +/- 11.9 mm Hg in controls and 37.1 +/- 9.1 mm Hg in patients treated with PDWHF. Initial wound area was larger in controls than in the patients treated with PDWHF (28.9 +/- 45.2 cm2 vs 13.0 +/- 14.4 cm2), but this difference was not statistically significant (p = 0.19). Three (33%) wounds (in two patients) healed in controls, and four (24%) wounds (in three patients) healed in the PDWHF group (p > 0.5). The rate of healing in controls was 1.9 +/- 2.7 cm2/week. Wounds in patients treated with PDWHF increased in size during treatment, averaging -4.3 +/- 12.2 cm2/week. This preliminary study suggests that treatment of chronic wounds with autologous PDWHF provides no additional benefit over traditional therapy.
引用
收藏
页码:526 / 536
页数:11
相关论文
共 31 条
[1]  
ANTONIADES HN, 1983, FED PROC, V42, P2630
[2]  
ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
[3]   TYPE-BETA TRANSFORMING GROWTH-FACTOR IN HUMAN-PLATELETS - RELEASE DURING PLATELET DEGRANULATION AND ACTION ON VASCULAR SMOOTH-MUSCLE CELLS [J].
ASSOIAN, RK ;
SPORN, MB .
JOURNAL OF CELL BIOLOGY, 1986, 102 (04) :1217-1223
[4]  
ATRI SC, 1990, SURGERY, V108, P508
[5]   ISOLATION OF A NONMITOGENIC ANGIOGENESIS FACTOR FROM WOUND FLUID [J].
BANDA, MJ ;
KNIGHTON, DR ;
HUNT, TK ;
WERB, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7773-7777
[6]   INOSITOL TRISPHOSPHATE, A NOVEL 2ND MESSENGER IN CELLULAR SIGNAL TRANSDUCTION [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1984, 312 (5992) :315-321
[7]   SEROTONIN RECEPTOR-MEDIATED STIMULATION OF BOVINE SMOOTH-MUSCLE CELL PROSTACYCLIN SYNTHESIS AND ITS MODULATION BY PLATELET-DERIVED GROWTH-FACTOR [J].
COUGHLIN, SR ;
MOSKOWITZ, MA ;
ANTONIADES, HN ;
LEVINE, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :7134-7138
[8]   PLATELET FACTOR-4 IS CHEMOTACTIC FOR NEUTROPHILS AND MONOCYTES [J].
DEUEL, TF ;
SENIOR, RM ;
CHANG, D ;
GRIFFIN, GL ;
HEINRIKSON, RL ;
KAISER, ET .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07) :4584-4587
[9]   CHEMOTAXIS OF MONOCYTES AND NEUTROPHILS TO PLATELET-DERIVED GROWTH-FACTOR [J].
DEUEL, TF ;
SENIOR, RM ;
HUANG, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (04) :1046-1049
[10]  
DUFF R, 1990, 3RD INT S TISS REP M